CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies

M. Romozzi; L. D. Nardo; V. Trigila; G. Cuffaro; Gustavo Savino; L. F. Iannone; Stanislao Rizzo; C. Vollono; Paolo Calabresi

doi:10.1136/jnnp-2025-335868

CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies

M. Romozzi^*, L. D. Nardo, V. Trigila, G. Cuffaro, Gustavo Savino, L. F. Iannone, Stanislao Rizzo, C. Vollono, Paolo Calabresi

^*Autore corrispondente per questo lavoro

University of Catania

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

In this case–control study, consecutive patients with a diagnosis of migraine according to ICHD-3 criteria were included, and tear fluid was collected from migraine patients and HCs. Clinical characteristics of migraine patients, including monthly headache days (MHDs), were recorded. The ictal phase was defined as the presence of a headache with migraine features (not lasting >24 hours).

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Journal of Neurology, Neurosurgery and Psychiatry
Numero di pubblicazione	N/A
DOI	https://doi.org/10.1136/jnnp-2025-335868
Stato di pubblicazione	Pubblicato - 2025

All Science Journal Classification (ASJC) codes

Chirurgia
Neurologia (clinica)
Psichiatria e Salute Mentale

Keywords

MIGRAINE
HEADACHE

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1136/jnnp-2025-335868

Altri file e collegamenti

Cita questo

@article{cbe2108b819d48d4ae684170d0a56a8e,

title = "CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies",

abstract = "In this case–control study, consecutive patients with a diagnosis of migraine according to ICHD-3 criteria were included, and tear fluid was collected from migraine patients and HCs. Clinical characteristics of migraine patients, including monthly headache days (MHDs), were recorded. The ictal phase was defined as the presence of a headache with migraine features (not lasting >24 hours).",

keywords = "MIGRAINE, HEADACHE, MIGRAINE, HEADACHE",

author = "M. Romozzi and Nardo, \{L. D.\} and V. Trigila and G. Cuffaro and Gustavo Savino and Iannone, \{L. F.\} and Stanislao Rizzo and C. Vollono and Paolo Calabresi",

year = "2025",

doi = "10.1136/jnnp-2025-335868",

language = "English",

pages = "N/A--N/A",

journal = "Journal of Neurology, Neurosurgery and Psychiatry",

issn = "0022-3050",

publisher = "BMJ / British Medical Journal Publishing Group:PO Box 299, London WC1H 9TD United Kingdom:011 44 20 73836270, EMAIL: [email protected], INTERNET: http://www.bmjpg.com/bmj, Fax: 011 44 20 73836402",

number = "N/A",

}

TY - JOUR

T1 - CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies

AU - Romozzi, M.

AU - Nardo, L. D.

AU - Trigila, V.

AU - Cuffaro, G.

AU - Savino, Gustavo

AU - Iannone, L. F.

AU - Rizzo, Stanislao

AU - Vollono, C.

AU - Calabresi, Paolo

PY - 2025

Y1 - 2025

N2 - In this case–control study, consecutive patients with a diagnosis of migraine according to ICHD-3 criteria were included, and tear fluid was collected from migraine patients and HCs. Clinical characteristics of migraine patients, including monthly headache days (MHDs), were recorded. The ictal phase was defined as the presence of a headache with migraine features (not lasting >24 hours).

AB - In this case–control study, consecutive patients with a diagnosis of migraine according to ICHD-3 criteria were included, and tear fluid was collected from migraine patients and HCs. Clinical characteristics of migraine patients, including monthly headache days (MHDs), were recorded. The ictal phase was defined as the presence of a headache with migraine features (not lasting >24 hours).

KW - MIGRAINE

KW - HEADACHE

KW - MIGRAINE

KW - HEADACHE

UR - https://publicatt.unicatt.it/handle/10807/318678

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105007532161&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105007532161&origin=inward

U2 - 10.1136/jnnp-2025-335868

DO - 10.1136/jnnp-2025-335868

M3 - Article

SN - 0022-3050

SP - N/A-N/A

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

IS - N/A

ER -

CGRP increase in tear fluid of migraine patients is reversed by anti-CGRP monoclonal antibodies

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo